Boundless Bio, Common Stock Analysis

Boundless Stock Analysis Notes

About 79.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.45. Some equities with similar Price to Book (P/B) outperform the market in the long run. Boundless Bio, Common recorded a loss per share of 2.59. The entity had not issued any dividends in recent years. The firm had 1:25 split on the March 31, 2011. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. Audentes Therapeutics, Inc. was founded in 2012 and is headquartered in San Francisco, California. Audentes Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people. For more info on Boundless Bio, Common please contact Zachary Hornby at 858 766 9912 or go to https://boundlessbio.com.

Boundless Bio, Common Investment Alerts

Boundless Largest EPS Surprises

View All Earnings Estimates

Boundless Bio, Environmental, Social, and Governance (ESG) Scores

Boundless Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 79.89 M.

Boundless Profitablity

Management Efficiency

Boundless Bio, Common has return on total asset (ROA) of (0.2369) % which means that it has lost $0.2369 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3574) %, meaning that it created substantial loss on money invested by shareholders. Boundless Bio,'s management efficiency ratios could be used to measure how well Boundless Bio, manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.41, whereas Return On Tangible Assets are forecasted to decline to (0.40). At present, Boundless Bio,'s Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.03, whereas Non Currrent Assets Other are forecasted to decline to about 527.2 K.

Technical Drivers

As of the 22nd of December, Boundless Bio, shows the Standard Deviation of 5.5, risk adjusted performance of (0.08), and Mean Deviation of 4.05. Boundless Bio, Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Boundless Bio, Common standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Boundless Bio, Common is priced correctly, providing market reflects its regular price of 2.59 per share. Please also double-check Boundless Bio, Common jensen alpha, which is currently at (0.64) to validate the company can sustain itself at a future point.

Boundless Bio, Common Price Movement Analysis

Boundless Bio, Common Insider Trading Activities

Boundless Bio, Predictive Daily Indicators

Boundless Bio, Forecast Models

Boundless Bio,'s time-series forecasting models are one of many Boundless Bio,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Boundless Bio,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Boundless Bio, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Boundless shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Boundless Bio,. By using and applying Boundless Stock analysis, traders can create a robust methodology for identifying Boundless entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Boundless analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Boundless analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Boundless Bio, Common stock analysis indicators help investors evaluate how Boundless Bio, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Boundless Bio, shares will generate the highest return on investment. By understating and applying Boundless Bio, stock analysis, traders can identify Boundless Bio, position entry and exit signals to maximize returns.

When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.